SerattaPure™ is the Boswellia Serrata extract standardised to 20% Boswellic acid content and formulated to enhance the bioavailability of the Boswellic acid. This product has been tested in Rats. The comparison studies are evident that SerattaPure™ has 2.37 times higher bioavailability than the reference standard. Also, in this study it is shown that the maximum absorption happens in the timeline of 1 hr after feeding the drug. Pre -Clinical studies are completed and results obtained are graphically represented below.
Recommended Daily Dose: 210 mg x 2 C/Day
Bioavailability studies, Anti-inflammatory, Joint pain
Acetyl-11-keto- -boswellic acid (AKBA) is a compound in Boswellia serrata that can increase free cytoplasmic calcium levels in human polymorphonuclear leukocyte (PMNL) cells. This increase may be due to endoplasmic reticulum leakage. Hence AKBA may be beneficial against bone loss during osteoporosis.
Pre-clinical studies were conducted for SerattaPure™ manufactured, formulated and marketed by Bio-Med Ingredients Pvt. Ltd with regular Marketed Boswellia Serrata Extract 65%. The objective of this study is to evaluate the Comparative Pharmacokinetic Study of SerattaPure™ with Boswellia Serrata Extract 65% in Sprague Dawley Rats by Oral Route. Based on the results obtained in the present study conditions, it can be concluded that the maximum absorption of SerattaPure™ has 2.37 times higher bioavailability than the reference standard and the maximum absorption happens in the timeline of 1 hr after administration of the drug.
Standardized Botanical Extracts, Patented Flagship Brands & Natural Colors
Select any target health goal to inspect clinical pairing recommendations.
Loading standardized botanical ingredients catalog...
Try adjusting your search query, or resetting health goal filters. Bio Med Ingredients also manufactures custom standardization ratios upon request.
